Skip to main content
logo
Exousia Bio, Inc. (LMMY)
OTCMKTS · Delayed Price · Currency is USD
0.0169
0.00 (0.00%)
Sep 17, 2026, 1:04 PM EST

Exousia Bio Financials Overview

Millions USD. Fiscal year is Jun - May.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingNov '25 May '25 May '24 May '23 May '22
Revenue
-00.01--
Revenue Growth
--67.39%---
Gross Profit
-0.07-00--
Operating Income
-0.28-0.03-0.03-0.05-0
Net Income
-0.080.05-0.03-0.06-0
Earnings Per Share
-0.010.01-0.00-0.01-
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingNov '25 May '25 May '24 May '23 May '22
Cash & Investments
--00.010.01
Total Debt
--0.060.060.05
Net Cash (Debt)
---0.06-0.05-0.04
Net Cash Growth
-----
Net Cash Per Share
---0.01-0.01-0.03

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingNov '25 May '25 May '24 May '23 May '22
Operating Cash Flow
0.09-0-0.01-0.04-0
Free Cash Flow
0.09-0-0.01-0.04-0
Free Cash Flow Growth
2.21%----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingNov '25 May '25 May '24 May '23 May '22
Gross Margin
--93.36%15.94%--
Operating Margin
--850.16%-228.20%--
Pretax Margin
-1370.53%-224.41%--
Profit Margin
-1370.53%-224.41%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 May '25 May '24 May '23 May '22
PE Ratio
-30.26---
PS Ratio
-414.77---